Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
This includes Ozempic, Wegovy, and Rybelsus
Tirzepatide is a novel glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for two distinct indications: type 2 diabetes mellitus (marketed as Mounjaro) and chronic weight management (marketed as Zepbound)
For example, Novo Nordisks latest quarterly financial results showed like-for-like revenue down 4% year on year at constant exchange rates, even though their GLP-1 sales for obesity treatment rose by more than 20%
Myth: Only Wegovy causes this side effect
US$ 23.32
US$ 22.68
US$ 26.43
US$ 25.01
